Medical Care
Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2025
- Mar 11, 25
- ID: 39733
- Pages: 76
- Figures: 75
- Views: 23
The global market for mRNA Cancer Vaccines and Therapeutics was valued at US$ 198 million in the year 2024 and is projected to reach a revised size of US$ 659 million by 2031, growing at a CAGR of 19.0% during the forecast period.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for mRNA Cancer Vaccines and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Cancer Vaccines and Therapeutics.
The mRNA Cancer Vaccines and Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Cancer Vaccines and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Cancer Vaccines and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Segment by Application
Infectious Disease
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Cancer Vaccines and Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
This report aims to provide a comprehensive presentation of the global market for mRNA Cancer Vaccines and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Cancer Vaccines and Therapeutics.
The mRNA Cancer Vaccines and Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Cancer Vaccines and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Cancer Vaccines and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Segment by Application
Infectious Disease
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Cancer Vaccines and Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2020-2031)
2.2 Global mRNA Cancer Vaccines and Therapeutics Growth Trends by Region
2.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 mRNA Cancer Vaccines and Therapeutics Market Dynamics
2.3.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2020-2025)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
3.5 Global Key Players of mRNA Cancer Vaccines and Therapeutics Head office and Area Served
3.6 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
3.7 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031)
5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.10.5 Tiba Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2020-2031)
2.2 Global mRNA Cancer Vaccines and Therapeutics Growth Trends by Region
2.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 mRNA Cancer Vaccines and Therapeutics Market Dynamics
2.3.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2020-2025)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
3.5 Global Key Players of mRNA Cancer Vaccines and Therapeutics Head office and Area Served
3.6 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
3.7 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031)
5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
11.10.5 Tiba Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Adeno Carcinomas
Table 3. Key Players of Mucinous Carcinomas
Table 4. Key Players of Adenosquamous Carcinomas
Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2020-2025)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2026-2031)
Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
Table 22. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Moderna Therapeutics Company Details
Table 48. Moderna Therapeutics Business Overview
Table 49. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 50. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Moderna Therapeutics Recent Development
Table 52. CureVac Company Details
Table 53. CureVac Business Overview
Table 54. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 55. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 56. CureVac Recent Development
Table 57. Translate Bio Company Details
Table 58. Translate Bio Business Overview
Table 59. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 60. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Translate Bio Recent Development
Table 62. BioNTech Company Details
Table 63. BioNTech Business Overview
Table 64. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 65. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 66. BioNTech Recent Development
Table 67. Sangamo Therapeutics Company Details
Table 68. Sangamo Therapeutics Business Overview
Table 69. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 70. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Sangamo Therapeutics Recent Development
Table 72. Argos Therapeutics Company Details
Table 73. Argos Therapeutics Business Overview
Table 74. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 75. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Argos Therapeutics Recent Development
Table 77. In-Cell-Art Company Details
Table 78. In-Cell-Art Business Overview
Table 79. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 80. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 81. In-Cell-Art Recent Development
Table 82. eTheRNA Company Details
Table 83. eTheRNA Business Overview
Table 84. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 85. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 86. eTheRNA Recent Development
Table 87. Ethris Company Details
Table 88. Ethris Business Overview
Table 89. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 90. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Ethris Recent Development
Table 92. Tiba Biotechnology Company Details
Table 93. Tiba Biotechnology Business Overview
Table 94. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 95. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Tiba Biotechnology Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Adeno Carcinomas Features
Figure 5. Mucinous Carcinomas Features
Figure 6. Adenosquamous Carcinomas Features
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Infectious Disease Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2024
Figure 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 21. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2020-2031)
Figure 33. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 49. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 50. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 51. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 52. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 53. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 54. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 55. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 56. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 57. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Adeno Carcinomas
Table 3. Key Players of Mucinous Carcinomas
Table 4. Key Players of Adenosquamous Carcinomas
Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2020-2025)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2026-2031)
Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
Table 22. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Moderna Therapeutics Company Details
Table 48. Moderna Therapeutics Business Overview
Table 49. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 50. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Moderna Therapeutics Recent Development
Table 52. CureVac Company Details
Table 53. CureVac Business Overview
Table 54. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 55. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 56. CureVac Recent Development
Table 57. Translate Bio Company Details
Table 58. Translate Bio Business Overview
Table 59. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 60. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Translate Bio Recent Development
Table 62. BioNTech Company Details
Table 63. BioNTech Business Overview
Table 64. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 65. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 66. BioNTech Recent Development
Table 67. Sangamo Therapeutics Company Details
Table 68. Sangamo Therapeutics Business Overview
Table 69. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 70. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Sangamo Therapeutics Recent Development
Table 72. Argos Therapeutics Company Details
Table 73. Argos Therapeutics Business Overview
Table 74. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 75. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Argos Therapeutics Recent Development
Table 77. In-Cell-Art Company Details
Table 78. In-Cell-Art Business Overview
Table 79. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 80. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 81. In-Cell-Art Recent Development
Table 82. eTheRNA Company Details
Table 83. eTheRNA Business Overview
Table 84. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 85. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 86. eTheRNA Recent Development
Table 87. Ethris Company Details
Table 88. Ethris Business Overview
Table 89. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 90. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Ethris Recent Development
Table 92. Tiba Biotechnology Company Details
Table 93. Tiba Biotechnology Business Overview
Table 94. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 95. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Tiba Biotechnology Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Adeno Carcinomas Features
Figure 5. Mucinous Carcinomas Features
Figure 6. Adenosquamous Carcinomas Features
Figure 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Infectious Disease Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2024
Figure 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 21. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2020-2031)
Figure 33. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 49. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 50. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 51. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 52. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 53. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 54. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 55. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 56. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 57. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232